Orthodox Jewish in UK disproportionately impacted by COVID-19

Researchers have conducted a study showing an extremely high prevalence of severe acute respiratory coronavirus disease 2 (SARS-CoV-2) within a strictly Orthodox Jewish community in the UK.

The SARS-CoV-2 virus is the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic that has now caused 105 million infections and more than 2.3 million deaths globally.

Evidence of an extremely high infection rate was observed across all age groups, with the highest rates seen among secondary school children and working-age adults, where prevalence reached 74%.

The analysis of serum from more than 1,200 participants showed that the seroprevalence of SARS-CoV-2 in this Jewish population was five times that estimated nationally and for London.

“In this tight-knit religious minority population in the UK, we report one of the highest SARS-CoV-2 seroprevalence levels in the world to date,” says the team from London School of Hygiene & Tropical Medicine and University College London.

The researchers say the findings provide further evidence that minority communities in the UK and elsewhere are disproportionately affected by the COVID-19 pandemic.

“Actions to reduce the burden of disease in this and other minority populations are urgently required,” writes Michael Marks and colleagues.

A pre-print version of the research paper is available on the medRxiv* server, while the article undergoes peer review.

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Minority groups in UK disproportionately impacted by COVID-19

The COVID-19 pandemic has disproportionately affected minority ethnic groups in the UK, which see higher numbers of SARS-CoV-2 infections and COVID-19 hospitalizations.

The reasons are likely multifactorial, with examples including larger household sizes, less opportunity to work from home, delayed access to healthcare, and relative socio-economic deprivation.

Marks and colleagues say that most studies to date have focused on larger minority ethnic groups and not on smaller groups, such as the Jewish community.

“In particular, strictly Orthodox Jewish communities had anecdotally reported high rates of infection, morbidity and hospitalization during the first wave of the UK pandemic,” writes the team. “In Spring 2020, a UK tightly-knit strictly-Orthodox Jewish community became aware that they appeared to be experiencing a high burden of SARS-CoV-2.”

What did the researchers do?

To measure the burden of infection and identify factors associated with transmission in a strictly Orthodox Jewish community, the researchers conducted a household-focused cross-sectional survey between late-October and early December 2020 – prior to the third national lockdown.

Individuals (n= 1,759) living in 343 randomly-selected households were asked to complete a standardized questionnaire covering demographics, comorbidities, previous SARS-CoV-2 testing, previous COVID-19 illness, access to healthcare, the severity of illness, and attendance at work, educational or other community locations.

Age specific seroprevalence in participants in the study. Colours indicate male and female participants.
Age specific seroprevalence in participants in the study. Colours indicate male and female participants.

All households were visited within 10 days of completing the survey and 1,242 participants underwent serological testing with a multiplex assay for SARS-CoV-2 immunoglobulin G (IgG) antibodies.

A multivariable random-effects logistic regression model was used to identify factors associated with SARS-CoV-2 infection and antibody titers.

What did the study find?

The overall seroprevalence for SARS-CoV-2 was 64.3%, ranging from 27.6% among children under 5 years-old to 73.8% among secondary-school children and 74.0% among working-age adults.

The researchers say the estimate of 64.3% seroprevalence is significantly higher than the national estimate of 6.9 % and 10.8% for London, resulting from random sampling performed in October by the Office for National Statistics.

“In this setting, there is a significant burden of disease in all age groups with secondary school-aged children having an equivalent seroprevalence to adults,” says the team.

“Over the course of 2020, the overall seroprevalence in this tightly knit religious community reached levels similar to those seen in Manaus, Brazil, where a seroprevalence of more than 65% has been reported in adults,” writes Michael Marks and colleagues.

Logistic regression analysis revealed that SARS-CoV-2 seropositivity was associated with increasing age, male gender, household size and being unable to work from home.

Seroprevalence was not associated with attendance at community gatherings or pre-existing comorbidities.

What do the authors advise?

The team says the findings point to an extremely high rate of SARS-CoV-2 infection in this strictly-Orthodox Jewish community.

“This provides further evidence that minority communities in the UK and elsewhere are disproportionately affected by the COVID-19 pandemic,” says Marks and colleagues.

The researchers say that contextually appropriate measures to reduce the burden of SARS-CoV-2 among minority populations specifically are urgently needed.

“Further studies to better understand drivers of transmission in ethnic and religious minority populations, conducted wherever possible in partnership with communities themselves, are urgently needed to reduce health disparities and improve outcomes for these populations,” concludes the team.

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Journal references:

Article Revisions

  • May 18 2023 - The preprint preliminary research paper that this article was based upon was accepted for publication in a peer-reviewed Scientific Journal. This article was edited accordingly to include a link to the final peer-reviewed paper, now shown in the sources section.
Sally Robertson

Written by

Sally Robertson

Sally first developed an interest in medical communications when she took on the role of Journal Development Editor for BioMed Central (BMC), after having graduated with a degree in biomedical science from Greenwich University.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Robertson, Sally. (2023, May 18). Orthodox Jewish in UK disproportionately impacted by COVID-19. News-Medical. Retrieved on November 21, 2024 from https://www.news-medical.net/news/20210207/Orthodox-Jewish-in-UK-disproportionately-impacted-by-COVID-19.aspx.

  • MLA

    Robertson, Sally. "Orthodox Jewish in UK disproportionately impacted by COVID-19". News-Medical. 21 November 2024. <https://www.news-medical.net/news/20210207/Orthodox-Jewish-in-UK-disproportionately-impacted-by-COVID-19.aspx>.

  • Chicago

    Robertson, Sally. "Orthodox Jewish in UK disproportionately impacted by COVID-19". News-Medical. https://www.news-medical.net/news/20210207/Orthodox-Jewish-in-UK-disproportionately-impacted-by-COVID-19.aspx. (accessed November 21, 2024).

  • Harvard

    Robertson, Sally. 2023. Orthodox Jewish in UK disproportionately impacted by COVID-19. News-Medical, viewed 21 November 2024, https://www.news-medical.net/news/20210207/Orthodox-Jewish-in-UK-disproportionately-impacted-by-COVID-19.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Link between COVID-19 and long-term risk of autoimmune and autoinflammatory connective tissue disorders